Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

PURPOSE: To evaluate safety and efficacy of combined transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEB) and sorafenib in patients with advanced hepatocellular carcinoma (HCC). PATIENTS AND METHODS: A prospective single-center phase II study was undertaken involving patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Pawlik, Timothy M., Reyes, Diane K., Cosgrove, David, Kamel, Ihab R., Bhagat, Nikhil, Geschwind, Jean-Francois H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829081/
https://ncbi.nlm.nih.gov/pubmed/21911714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.1021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados